Reaction
Gingival Hypertrophy reporting signals
As of the last recalculation, Gingival Hypertrophy appears in 1,482 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is PHENYTOIN (PRR 60.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Phenytoin | 85 | 60.6 | 60.9 |
| Anti-Thymocyte Globulin (Rabbit) | 26 | 46.1 | 46.2 |
| Cyclosporine | 231 | 34.4 | 34.4 |
| Amlodipine | 446 | 32.8 | 32.9 |
| Nifedipine | 81 | 25.4 | 25.5 |
| Phenobarbital | 25 | 24.6 | 24.7 |
| Captopril | 16 | 23.6 | 23.7 |
| Extended Phenytoin Sodium | 23 | 19.6 | 19.6 |
| Felodipine Extended-Release Tablets | 15 | 18.7 | 18.7 |
| Felodipine | 15 | 18.7 | 18.7 |
| Mycophenilic Acid | 26 | 17.9 | 17.9 |
| Tacrolimus Ointment 0.1% | 141 | 17.5 | 17.5 |
| Tacrolimus Extended-Release Capsules | 141 | 17.4 | 17.4 |
| Mycophenolate Mofetil Hydrochloride | 151 | 17.2 | 17.3 |
| Mycophenolate Mofetil | 150 | 17.1 | 17.2 |
| Voclosporin | 10 | 16.3 | 16.3 |
| Tacrolimus | 150 | 14.9 | 14.9 |
| Amlodipine Besylate | 134 | 14.0 | 14.0 |
| Clobazam | 24 | 14.0 | 14.0 |
| Valproic Acid | 30 | 13.6 | 13.6 |
| Mycophenolic Acid | 28 | 12.5 | 12.5 |
| Eltrombopag Olamine | 20 | 12.3 | 12.3 |
| Indapamide | 14 | 11.1 | 11.1 |
| Insulin Glargine-Yfgn | 16 | 10.4 | 10.4 |
| Abacavir Sulfate | 7 | 10.1 | 10.1 |
| Enalapril | 37 | 9.6 | 9.6 |
| Azacitidine For | 11 | 8.5 | 8.6 |
| Levetiracetam In Sodium Chloride | 37 | 6.9 | 6.9 |
| Levetiracetam Oral | 37 | 6.9 | 6.9 |
| Levetiracetam Injection | 37 | 6.9 | 6.9 |
| Brivaracetam | 4 | 6.3 | 6.3 |
| Cannabidiol | 10 | 6.0 | 6.0 |
| Azacitidine | 12 | 5.7 | 5.7 |
| Vigabatrin | 5 | 4.8 | 4.8 |
| Vemurafenib | 4 | 4.7 | 4.7 |